Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc KNBIF


Primary Symbol: V.KNE

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech Announces First Quarter 2020 Financial Results

GlobeNewswire May 21, 2020

Kane Biotech Recommences Trading on the OTCQB Venture Market

GlobeNewswire May 19, 2020

Kane Biotech to Release First Quarter 2020 Financial Results on May 21 - Conference Call to Follow

GlobeNewswire May 14, 2020

Kane Biotech Announces Further Extension of Warrants

GlobeNewswire May 14, 2020

Kane Biotech Reports Positive Results from Anti-Biofilm Shampoo Consumer Product Test

GlobeNewswire May 12, 2020

Kane Biotech Provides an Update Regarding Its Response to COVID-19

GlobeNewswire May 7, 2020

Kane Biotech Announces Fourth Quarter and Full Year 2019 Financial Results

GlobeNewswire April 2, 2020

Kane Biotech Reschedules Release of Fourth Quarter and Full Year 2019 Financial Results and Associated Conference Call to April 2, 2020

GlobeNewswire March 25, 2020

Kane Biotech to Release Fourth Quarter and Full Year 2019 Financial Results on March 26 - Conference Call to Follow

GlobeNewswire March 20, 2020

Kane Biotech Announces Grant of Stock Options

GlobeNewswire March 2, 2020

Kane Biotech Launches silkstem(TM) Anti-Itch Shampoo at the Global Pet Expo

GlobeNewswire February 26, 2020

Kane Biotech Signs First U.S. Distribution Agreement with King Wholesale Inc.

GlobeNewswire February 25, 2020

Kane Biotech Announces Closing of Second and Final Tranche of Private Placement

GlobeNewswire February 24, 2020

Kane Biotech Welcomes Renowned Canadian Veterinarian, Dr. Jean Gauvin, as Chief Veterinary Officer

GlobeNewswire February 20, 2020

Kane Biotech Engages Independent Trading Group, Inc. for Market-Making Services

GlobeNewswire January 27, 2020

Kane Biotech Provides Update on Previously Announced Private Placement

GlobeNewswire January 23, 2020

Kane Biotech Announces Closing of First Tranche of Private Placement

GlobeNewswire December 19, 2019

Kane Biotech Announces Fulfilment of First Major Animal Oral Care Product Order from China

GlobeNewswire December 17, 2019

Kane Biotech Launches Consumer Product Test for an Innovative Shampoo Containing its Patented Anti-Biofilm Technology

GlobeNewswire December 16, 2019

Kane Biotech Announces Private Placement Offering

GlobeNewswire December 4, 2019